Aspira Pathlab Diagnostics Ltd vs Dolphin Medical Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of Dolphin Medical Services Ltd is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of Dolphin Medical Services Ltd is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of Dolphin Medical Services Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of Dolphin Medical Services Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of Dolphin Medical Services Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dolphin Medical Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Dolphin Medical Services Ltd

Dolphin Medical Services Limited, established in September, 1992 is an organization promoted by the doctors from the coastal region of Andhra Pradesh.
The Chief Promoters are Dr. M. S. S. Koteswara Rao, an eminent physician and former Minister for Health in Andhra Pradesh and Dr. G. V. Mohan Prasad, a Radiologist cum ENT specialist. The Company has been providing comprehensive Diagnostic Services since 1994, with a range of tests covering Radiology and Imaging, Biochemistry, Pathology and Microbiology etc., to the people of the coastal region of Andhra Pradesh. The Company was able to withstand the tough competition in the market and still enhance its profitability of the Company.
The present status of the Company is that the Company was debt free and later made profit making for past many years.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Dolphin Medical Services Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Dolphin Medical Services Ltd is 9 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd?

As of October 24, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Dolphin Medical Services Ltd stock price is INR ₹6.54.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Dolphin Medical Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.